news - TUNECT

Public review of version 1.0 of the Rare Diseases Therapeutic Area User Guide

Exciting News for SAS Programmers in Rare Disease Research!

Succeed in organization and conducting the iDMC for Phase I, Randomized, Double Blind, Placebo-Controlled, Safety, Reactogenicity, and Immunogenicity Trial of the SARS-CoV-2 Vaccine

We are thrilled to share some incredible updates from the TUNECT CRO team

Previous 1 … 4 5 6 7

This website uses cookies to improve your experience. If you continue to use this site, you agree with it.